FibroGen’s anemia drug fails to meet main goal in late-stage trial Posted on 06/05/2023 by IDHubAdmin The drug was being studied for the treatment of anemia in patients with a type of bone marrow cancer who are dependent on transfusion. The primary goal of the study had been transfusion independence … Spread the love